Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Purpose To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab. Methods Case report. Results A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the...

Full description

Saved in:
Bibliographic Details
Published in:International ophthalmology Vol. 38; no. 2; pp. 781 - 785
Main Authors: Makragiannis, Georgios, Vahdani, Kaveh, Carreño, Ester, Lee, Richard W. J., Dick, Andrew D., Ross, Adam H.
Format: Journal Article
Language:English
Published: Dordrecht Springer Netherlands 01-04-2018
Springer Nature B.V
Subjects:
Angiography
Bevacizumab
Case Report
Case reports
Chorioretinitis
Fluorescein
Immunotherapy
Licenses
Medical imaging
Medicine
Medicine & Public Health
Monoclonal antibodies
Ophthalmology
Optical Coherence Tomography
Patients
Vascularization
Chorioretinitis
Candida
Choroidal neovascular membrane
Bevacizumab
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab. Methods Case report. Results A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT. Conclusions Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0165-5701
1573-2630
DOI:10.1007/s10792-017-0502-x